Unraveling the internal drivers of pharmaceutical company performance in Europe: A DEMATEL analysis
DOI:
https://doi.org/10.24136/eq.2896Keywords:
internal drivers, performance of pharmaceutical companies, DEMATEL, EuropeAbstract
Research background: Internal business factors are vital to how a company achieves its goals. The present study of internal drivers of pharmaceutical company performance is very insightful, as it has the potential to boost further competitiveness, it may allow health authority personnel to have guidelines to make strategic decisions, as well as inspire investor confidence, ensure regulatory compliance and performance benchmarking, and support talent acquisition and retention. In addition, it can identify the important internal factors that need to receive more priority.
Purpose of the article: The European pharmaceutical industry is currently facing multiple challenges. This paper aims to map the relative relationships among the internal factors that influence the business performance of pharmaceutical companies in Europe by using the DEMATEL approach.
Method: There are two phases of the present study, an extensive literature review and the use of the decision-making trial and evaluation laboratory (DEMATEL) technique. To identify the key internal drivers and their cause-and-effect relationship with pharmaceutical company performance in Europe, data from experts were obtained using the predesigned DEMATEL questionnaire.
Findings & value added: The extensive literature review from the Web of Science and Scopus databases found that seven internal factors are very demanding in the case of European pharmaceutical business performance. The main elements that have the highest impact on pharmaceutical business performance in Europe are human resources competencies, the information system, technological competitiveness, and the patent system. However, financial profitability, research and development competencies, alliances with other companies, and supply chain management are the factors that are affected more by other factors.
The study is the first attempt to identify the internal business performance of the pharmaceutical sector in Europe by working with pragmatic and perceptive decisions from pharmaceutical stakeholders in Europe.
Downloads
References
Abbasi, S., Aghakhani, H., Azizi, S., Peikanpour, M., & Mehralian, G. (2023). Corporate social responsibility and customer loyalty during the Covid-19 pandemic: Evidence from pharmacy practise. Social Responsibility Journal, 19(2), 249–263.
DOI: https://doi.org/10.1108/SRJ-06-2021-0243
View in Google Scholar
Alharthi, S. A. K., Cerotti, P., & Far, S. M. (2020). Investigating the impact of blockchain implementation on pharmaceutical supply chain sustainability. In Proceedings paper at 35th International-Business-Information-Management-Association conference (IBIMA) (pp. 9231–9252). IBIMA.
View in Google Scholar
Araujo, T. R. D., Jugend, D., Pimenta, M. L., Jesus, G. M. K., Barriga, G. D. D. C., Toledo, J. C. D., & Mariano, A. M. (2022). Influence of new product development best practices on performance: An analysis in innovative Brazilian companies. Journal of Business & Industrial Marketing, 37(2), 266–281.
DOI: https://doi.org/10.1108/JBIM-07-2020-0362
View in Google Scholar
Asad, A. I., & Popesko, B. (2023). Contemporary challenges in the European pharmaceutical industry: A systematic literature review. Measuring Business Excellence, 27(2), 277–290.
DOI: https://doi.org/10.1108/MBE-09-2021-0112
View in Google Scholar
Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., & Supuran, C. T. (2021). Natural products in drug discovery: Advances and opportunities. Nature Reviews Drug Discovery, 20(3), 200–216.
DOI: https://doi.org/10.1038/s41573-020-00114-z
View in Google Scholar
Bala, H., Massey, A. P., & Montoya, M. M. (2017). The effects of process orientations on collaboration technology use and outcomes in product development. Journal of Management Information Systems, 34(2), 520–559.
DOI: https://doi.org/10.1080/07421222.2017.1334494
View in Google Scholar
Ballano, V. (2023). Catholic social teaching, human dignity, and the common good: Exploring the major factors affecting Big Pharma’s corporate moral responsibility during COVID-19. Business and Professional Ethics Journal, 42(3), 291–314.
DOI: https://doi.org/10.5840/bpej20231017145
View in Google Scholar
Bereznoy, A. (2022). Transformation of Big Pharma business models. Mirovaia Ekonomika i Mezhdunarodnye Otnosheniia, 66(3), 81–89.
DOI: https://doi.org/10.20542/0131-2227-2022-66-3-81-89
View in Google Scholar
Boddu, R. S. K., Ahamad, S., Kumar, K. P., Ramalingam, M., Pallathadka, L. K., & Tupas, F. P. (2022). Analysis of robotics, artificial intelligence and machine learning in the field of healthcare sector. Materials Today: Proceedings, 56, 2323–2327.
DOI: https://doi.org/10.1016/j.matpr.2021.12.016
View in Google Scholar
Boldeanu, D. M., & Gheorghe, M. (2012). Multidimensional analysis of firm’s financial performance through the influence factors in pharmaceutical sector. In Proceedings of the international conference accounting and management information systems AMIS 2012 (pp. 1049–1060). Bucharest: Bucharest University of Economic Studies.
View in Google Scholar
Boldeanu, D. M., & Pugna, I. B. (2014). The analysis of the influence factors affecting the performance of pharmaceutical companies. Theoretical & Applied Economics, 21(7), 23–42.
View in Google Scholar
Bousalem, R., & Aichouche, K. (2016). Presenting a model of critical success factors for organizational innovation in Algerian Pharmaceutical Company. In 2016 international conference on digital economy (ICDEc) (pp. 45–52). IEEE. doi: 10.1109/ICDEC.2016.7563144.
DOI: https://doi.org/10.1109/ICDEC.2016.7563144
View in Google Scholar
Chai, K. C., Tao, R., Chang, K. C., & Yang, Y. (2020). Impact of China's vaccine incidents on the operational efficiency of biopharmaceutical companies. Frontiers in Public Health, 8(93), 1–8.
DOI: https://doi.org/10.3389/fpubh.2020.00093
View in Google Scholar
Ciliberti, S., Carraresi, L., & Bröring, S. (2016). Drivers of innovation in Italy: Food versus pharmaceutical industry. British Food Journal, 118(6), 1292–1316.
DOI: https://doi.org/10.1108/BFJ-10-2015-0405
View in Google Scholar
Dadfar, H., Brege, S., Golizeh, M., & Ghasemi, H. (2010). Corporate governance in pharmaceutical industry: The case of TAPIC pharmaceutical group. In 6th European conference on management, leadership and governance (ECMLG 2010) (pp. 83–93). Academic Conferences Limited.
View in Google Scholar
de Campos, E. A. R., Tavana, M., Ten Caten, C. S., Bouzon, M., & de Paula, I. C. (2021). A grey-DEMATEL approach for analysing factors critical to the implementation of reverse logistics in the pharmaceutical care process. Environmental Science and Pollution Research, 28(11), 14156–14176.
DOI: https://doi.org/10.1007/s11356-020-11138-8
View in Google Scholar
Doloreux, D., Shearmur, R., & Rodriguez, M. (2016). Determinants of R&D in knowledge-intensive business services firms. Economics of Innovation and New Technology, 25(4), 391–405.
DOI: https://doi.org/10.1080/10438599.2015.1067001
View in Google Scholar
Donkor, F., Papadopoulos, T., & Spiegler, V. (2022). Supply chain integration and supply chain sustainability relationship: A qualitative analysis of the UK and Ghana pharmaceutical industry. Production Planning & Control, 35(6), 535–558.
DOI: https://doi.org/10.1080/09537287.2022.2105762
View in Google Scholar
Downs, J. B., & Velamuri, V. K. (2018). Business model innovation in a knowledge revolution: An evolutionary theory perspective. Managerial and Decision Economics, 39(5), 550–562.
DOI: https://doi.org/10.1002/mde.2926
View in Google Scholar
Du, Y. W., & Zhou, W. (2019). New improved DEMATEL method based on both subjective experience and objective data. Engineering Applications of Artificial Intelligence, 83, 57–71.
DOI: https://doi.org/10.1016/j.engappai.2019.05.001
View in Google Scholar
Enekwe, C. I., Agu, C. I., & Eziedo, K. N. (2014). The effect of financial leverage on financial performance Evidence of quoted pharmaceutical companies in Nigeria. IOSR Journal of Economics and Finance, 5(3), 17–25.
DOI: https://doi.org/10.9790/5933-0531725
View in Google Scholar
Estler, M., & Ewen, J. (2011). Overcoming boundaries by "production intelligence". Pharmazeutische Industrie, 73(3), 566–573.
View in Google Scholar
European Commission (2020). Pharmaceutical strategy for Europe, 2020. Retrieved from https://health.ec.europa.eu/system/files/2021-02/pharma-strategy_report_ en_0.pdf.
View in Google Scholar
European Parliament (2021). European pharmaceutical research and development: Could public infrastructure overcome market failures? European Parliamentary Research Service, Brussels. Retrieved from https://www.europarl.europa.eu/Reg Data/etudes/STUD/2021/697197/EPRS_STU(2021)697197
View in Google Scholar
European Parliament (2023). Artificial intelligence: threats and opportunities. Retrieved from https://www.europarl.europa.eu/news/en/headlines/society/202009 18STO87404/artificial-intelligence-threats-and-opportunities.
View in Google Scholar
Eva, G. (2018). New health technologies as one of the key drivers of healthcare spending growth in the Czech Republic. In Proceedings of the 22nd international conference current trends in public sector research (pp. 244–251). Brno: Masaryk University.
View in Google Scholar
Ferreira, T. S. (2017). Motivational factors in sales team management and their influence on individual performance. Tourism & Management Studies, 13(1), 60–65.
DOI: https://doi.org/10.18089/tms.2017.13108
View in Google Scholar
Frank, M., Jaeger, L., & Ranft, L. M. (2023). Using contextual factors to predict information security overconfidence: A machine learning approach. Computers & Security, 125, 103046.
DOI: https://doi.org/10.1016/j.cose.2022.103046
View in Google Scholar
Galende, J., & de la Fuente, J. M. (2003). Internal factors determining a firm’s innovative behaviour. Research Policy, 32(5), 715–736.
DOI: https://doi.org/10.1016/S0048-7333(02)00082-3
View in Google Scholar
Gaol, F. L., Rahayu, S., & Matsuo, T. (2020). The development of information system with strategic planning for integrated system in the Indonesian pharmaceutical company. Open Engineering, 10(1), 721–732.
DOI: https://doi.org/10.1515/eng-2020-0081
View in Google Scholar
Gascón, F., Lozano, J., Ponte, B., & de la Fuente, D. (2017). Measuring the efficiency of large pharmaceutical companies: An industry analysis. European Journal of Health Economics, 18(5), 587–608.
DOI: https://doi.org/10.1007/s10198-016-0812-3
View in Google Scholar
Ghauri, E. (2018). Performance evaluation of sales employees: A comparative investigation in the pharmaceutical industry. International Journal of Business Performance Management, 19(3), 253–279.
DOI: https://doi.org/10.1504/IJBPM.2018.092756
View in Google Scholar
Glenn Richey Jr, R., Chen, H., Upreti, R., Fawcett, S. E., & Adams, F. G. (2009). The moderating role of barriers in the relationship between drivers to supply chain integration and firm performance. International Journal of Physical Distribution & Logistics Management, 39(10), 826–840.
DOI: https://doi.org/10.1108/09600030911011432
View in Google Scholar
Hall, L. A., & Bagchi-Sen, S. (2002). A study of R&D, innovation, and business performance in the Canadian biotechnology industry. Technovation, 22(4), 231–244.
DOI: https://doi.org/10.1016/S0166-4972(01)00016-5
View in Google Scholar
Hansen, Z. N. L., Andreu, C. M., Khan, O., Haug, A., Hvam, L., & Hansen, N. E. (2023). Identification of key drivers for improving inventory management in pharmaceutical supply chains. Production Engineering, 17(5), 763–772.
DOI: https://doi.org/10.1007/s11740-023-01199-2
View in Google Scholar
Haque, M., & Islam, R. (2018). Impact of supply chain collaboration and knowledge sharing on organizational outcomes in pharmaceutical industry of Bangladesh. Journal of Global Operations and Strategic Sourcing, 11(3), 301–320.
DOI: https://doi.org/10.1108/JGOSS-02-2018-0007
View in Google Scholar
Hassan, N. A., Mohammad Zailani, S. H., & Hasan, H. A. (2021). A meta-analysis of integrated internal audit management effectiveness towards business sustainability. Pertanika Journal of Social Sciences & Humanities, 29(S2), 233–252.
DOI: https://doi.org/10.47836/pjssh.29.s2.16
View in Google Scholar
Izadpanah, F., Shiehmorteza, M., Rahimpour, A., & Moradi, M. (2020). Prioritizing medication management criteria of national hospital accreditation standards using FDANP model. Journal of Pharmaceutical Research International, 32(3), 69–77.
DOI: https://doi.org/10.9734/jpri/2020/v32i330415
View in Google Scholar
Jaberidoost, M., Nikfar, S., Abdollahiasl, A., & Dinarvand, R. (2013). Pharmaceutical supply chain risks: A systematic review. DARU Journal of Pharmaceutical Sciences, 21(69), 1–7.
DOI: https://doi.org/10.1186/2008-2231-21-69
View in Google Scholar
Jassbi, A., Jafari, M., Mahdavi Mazdeh, M., & Maleki, M. (2021). Structural model of foresightful export-oriented strategies for Iran pharmaceutical industry using the Fuzzy DEMATEL method. Iranian Red Crescent Medical Journal, 23(11), 1–8.
View in Google Scholar
Jayamohan, P., Moss, T., McKelvie, A., & Hyman, M. (2024). The influence of managerial attributions on corporate entrepreneurship. Journal of Management & Organization, 30(1), 18–39.
DOI: https://doi.org/10.1017/jmo.2022.7
View in Google Scholar
Jiang, H., Wang, Z., Gao, S., Chen, K., & Sheng, F. (2022). Enhancing technology innovation performance through alliance capability: The role of standard alliance network and political skill of TMTs. Frontiers in Psychology, 13, 1008857.
DOI: https://doi.org/10.3389/fpsyg.2022.1008857
View in Google Scholar
Jolly, A., Nicol, L., Waters, J., & Wight, C. (2005). Drivers affecting the pharmaceutical industry: How much is changing?. Journal of Medical Marketing, 5(2), 146–157.
DOI: https://doi.org/10.1057/palgrave.jmm.5040220
View in Google Scholar
Jongh, T., Becker, D., Boulestreau, M., Dave, A., Dijkstal, F., King, R., Petrosova, L., Varnal, P., Vis, C., Spit, W., Moulac, M., & Pelsy, F. (2021). Future-proofing pharmaceutical legislation – Study on medicine shortages – Final report (revised), Publications Office of the European Union. Retrieved from https://data.europa.eu/doi/10.2875/211485.
View in Google Scholar
Kabak, Ö., Ülengin, F., Çekyay, B., Önsel, Ş., & Özaydın, Ö. (2016). Critical success factors for the iron and steel industry in Turkey: A fuzzy DEMATEL approach. International Journal of Fuzzy Systems, 18, 523–536.
DOI: https://doi.org/10.1007/s40815-015-0067-7
View in Google Scholar
Kayani, S. A., Warsi, S. S., & Liaqait, R. A. (2023). A smart decision support framework for sustainable and resilient supplier selection and order allocation in the pharmaceutical industry. Sustainability, 15(7), 5962.
DOI: https://doi.org/10.3390/su15075962
View in Google Scholar
Khan, S. A., Gupta, H., Gunasekaran, A., Mubarik, M. S., & Lawal, J. (2023). A hybrid multi‐criteria decision‐making approach to evaluate interrelationships and impacts of supply chain performance factors on pharmaceutical industry. Journal of Multi‐Criteria Decision Analysis, 30(1-2), 62–90.
DOI: https://doi.org/10.1002/mcda.1800
View in Google Scholar
Klinge, T. J., Fernandez, R., & Aalbers, M. B. (2020). The financializetion of big pharma. Revista Internacional de Sociologia, 78(4), e174.
DOI: https://doi.org/10.3989/ris.2020.78.4.m20.006
View in Google Scholar
Kumar, A., Kaviani, M. A., Bottani, E., Dash, M. K., & Zavadskas, E. K. (2018). Investigating the role of social media in polio prevention in India: A Delphi-DEMATEL approach. Kybernetes, 47(5), 1053–1072.
DOI: https://doi.org/10.1108/K-06-2017-0210
View in Google Scholar
Kumar, D., & Chandra, D. (2022). A hybrid framework to model resilience in the generic medicine supply chain of MSMEs. Benchmarking: An International Journal, 30(6), 2189–2224.
DOI: https://doi.org/10.1108/BIJ-11-2021-0697
View in Google Scholar
Lee, H. S., Tzeng, G. H., Yeih, W., Wang, Y. J., & Yang, S. C (2013). Revised DEMATEL: Resolving the infeasibility of DEMATEL. Applied Mathematical Modelling, 37(10-11), 6746–6757.
DOI: https://doi.org/10.1016/j.apm.2013.01.016
View in Google Scholar
Li, X., & Hamblin, D. (2016). Factors impacting on cleaner production: Case studies of Chinese pharmaceutical manufacturers in Tianjin, China. Journal of Cleaner Production, 131, 121–132.
DOI: https://doi.org/10.1016/j.jclepro.2016.05.066
View in Google Scholar
Ling, T. C., Fern, Y. S., Ang, P. T., & Ching, S. L. (2018). Examining the priority variables on the R&D engineer’s innovativeness: An importance-performance matrix analysis (IPMA) approach. In ICMLG 2018 6th international conference on management leadership and governance (pp. 69–77). Academic Conferences and Publishing Limited.
View in Google Scholar
Luu, D. T., Ho, D. P., Hiep, N. T. K., Hoi, P. T., & Hanh, D. T. P. (2019). Job satisfaction, leadership styles, demographic variables, and organisational commitment among pharmacists in Vietnam. South East Asian Journal of Management, 13(1), 37–52.
DOI: https://doi.org/10.21002/seam.v13i1.10693
View in Google Scholar
Mahdiraji, H. A., Kamardi, A. A., Beheshti, M., Hajiagha, S. H. R., & Rocha-Lona, L. (2022). Analysing supply chain coordination mechanisms dealing with repurposing challenges during Covid-19 pandemic in an emerging economy: A multi-layer decision making approach. Operations Management Research, 15(3-4), 1341–1360.
DOI: https://doi.org/10.1007/s12063-021-00224-w
View in Google Scholar
Mahssouni, R., Touijer, M. N., & Makhroute, M. (2022). Employee compensation, training, and financial performance during the COVID-19 pandemic. Journal of Risk and Financial Management, 15(12), 559.
DOI: https://doi.org/10.3390/jrfm15120559
View in Google Scholar
Małys, Ł. (2023). The approach to supply chain cooperation in the implementation of sustainable development initiatives and company’s economic performance. Equilibrium. Quarterly Journal of Economics and Economic Policy, 18(1), 255–286.
DOI: https://doi.org/10.24136/eq.2023.008
View in Google Scholar
Meidute-Kavaliauskiene, I., Cebeci, H. I., Ghorbani, S., & Činčikaitė, R. (2021). An integrated approach for evaluating lean innovation practices in the pharmaceutical supply chain. Logistics, 5(4), 74.
DOI: https://doi.org/10.3390/logistics5040074
View in Google Scholar
Mendigorri, E. M., Valderrama, T. G., & Cornejo, V. R. (2016). Measuring the effectiveness of R & D activities: Empirical validation of a scale in the Spanish pharmaceutical sector. Management Decision, 54(2), 321–362.
DOI: https://doi.org/10.1108/MD-06-2014-0378
View in Google Scholar
Moosivand, A., Ghatari, A. R., & Rasekh, H. R. (2019). Supply chain challenges in pharmaceutical manufacturing companies: Using qualitative system dynamics methodology. Iranian Journal of Pharmaceutical Research: IJPR, 18(2), 1103–1116.
View in Google Scholar
Naeem, R. M., Channa, K. A., Hameed, Z., Ali Arain, G., & Islam, Z. U. (2021). The future of your job represents your future: A moderated mediation model of transformational leadership and job crafting. Personnel Review, 50(1), 207–224.
DOI: https://doi.org/10.1108/PR-07-2019-0404
View in Google Scholar
Nazari, J. A., & Ghasemzadeh, P. (2018). The effects of knowledge creation process on organizational performance using the BSC approach: The mediating role of intellectual capital. Journal of Knowledge Management, 22(4), 802–823.
DOI: https://doi.org/10.1108/JKM-10-2016-0457
View in Google Scholar
Nguyen, T. (2021). The effect of internal control on the performance of pharmaceutical firms in Vietnam. Accounting, 7(2), 395–400.
DOI: https://doi.org/10.5267/j.ac.2020.11.012
View in Google Scholar
Ohana, P., Tardieu, S., Blin, O., Tassy, S., & Sambuc, R. (2004). Drug patents and other ways to protect pharmaceutical research. Therapie, 59(2), 253–257.
DOI: https://doi.org/10.2515/therapie:2004049
View in Google Scholar
Ombrosi, N., Casprini, E., & Piccaluga, A. (2019). Designing and managing co-innovation: The case of Loccioni and Pfizer. European Journal of Innovation Management, 22(4), 600–616. https://doi.org/0.1108/EJIM-09-2018-0196.
DOI: https://doi.org/10.1108/EJIM-09-2018-0196
View in Google Scholar
Ortiz, B., Donate, M. J., & Guadamillas, F. (2021). Intra-organizational social capital and product innovation: The mediating role of realised absorptive capacity. Frontiers in Psychology, 11, 624189.
DOI: https://doi.org/10.3389/fpsyg.2020.624189
View in Google Scholar
Pinto, G., & Rastogi, S. (2022). Corporate governance impact on dividend policy of NIFTY-500 indexed Indian pharmaceutical companies (2014–2019). Corporate Governance, 22(7), 1547–1566.
DOI: https://doi.org/10.1108/CG-08-2021-0309
View in Google Scholar
Pinto, H., Guerreiro, J. A., & Fernández-Esquinas, M. (2023). Sources of knowledge in the firm: A review on influential, internal, and contextual factors in innovation dynamics. SN Business & Economics, 3(57), 1–32.
DOI: https://doi.org/10.1007/s43546-023-00430-7
View in Google Scholar
Raghavendra, M. S., Raj, J. R., & Seetharaman, A. (2012). A study of decrease in R&D spending in the pharmaceutical industry during post-recession. International Journal of Academic Research, 4(5), 29–47.
DOI: https://doi.org/10.7813/2075-4124.2012/4-5/B.6
View in Google Scholar
Riantoputra, D. C. (2010). Know thyself: Examining factors that influence the activation of organizational identity concepts in top managers’ minds. Group & Organisation Management, 35(1), 8–38.
DOI: https://doi.org/10.1177/1059601109354804
View in Google Scholar
Rocha, M. D. M., de Andrade, E. P., Alves, E. R., Cândido, J. C., & Borio, M. D. M. (2020). Access to innovative medicines by pharma companies: Sustainable initiatives for global health or useful advertisement?. Global Public Health, 15(6), 777–789.
DOI: https://doi.org/10.1080/17441692.2020.1729391
View in Google Scholar
Rouhani, S., Ashrafi, A., & Afshari, S. (2014). Fuzzy DEMATEL model for evaluation criteria of business intelligence. In International conference on enterprise information systems (pp. 456–463). SciTePress.
View in Google Scholar
Sabary, G. S., & Ključnikov, A. (2023). Barriers to immigrant entrepreneurship: A causal relationship analysis of the Asian immigrant entrepreneurs in Germany employing the DEMATEL approach. Equilibrium. Quarterly Journal of Economics and Economic Policy, 18(2), 491–522.
DOI: https://doi.org/10.24136/eq.2023.015
View in Google Scholar
Sabary, G. S., Durda, L., Asad, A. I., & Ključnikov, A. (2023). Key motivational factors behind Asian immigrant entrepreneurship: A causal relationship analysis employing the DEMATEL approach for Germany. Equilibrium. Quarterly Journal of Economics and Economic Policy, 18(1), 275–318.
DOI: https://doi.org/10.24136/eq.2023.009
View in Google Scholar
Schapranow, M. P., Müller, J., Zeier, A., & Plattner, H. (2012). Secure RFID-enablement in modern companies: A case study of the pharmaceutical industry. In Handbook of research on industrial informatics and manufacturing intelligence: Innovations and solutions (pp. 507–539). IGI Global.
DOI: https://doi.org/10.4018/978-1-4666-0294-6.ch022
View in Google Scholar
Shafiee, M., Zare-Mehrjerdi, Y., Govindan, K., & Dastgoshade, S. (2022). A causality analysis of risks to perishable product supply chain networks during the COVID-19 outbreak era: An extended DEMATEL method under Pythagorean fuzzy environment. Transportation Research Part E: Logistics and Transportation Review, 163, 102759.
DOI: https://doi.org/10.1016/j.tre.2022.102759
View in Google Scholar
Sharma, M., Sehrawat, R., Luthra, S., Daim, T., & Bakry, D. (2022). Moving towards industry 5.0 in the pharmaceutical manufacturing sector: Challenges and solutions for Germany. IEEE Transactions on Engineering Management. 1–18.
DOI: https://doi.org/10.1109/TEM.2022.3143466
View in Google Scholar
Singh, S., Singh, S., & Misra, S. C. (2023). Post-implementation challenges of ERP system in pharmaceutical companies. International Journal of Quality & Reliability Management, 40(4), 889–921.
DOI: https://doi.org/10.1108/IJQRM-10-2020-0333
View in Google Scholar
Styhre, A. (2002), The knowledge-intensive company and the economy of sharing: Rethinking utility and knowledge management. Knowledge and Process Management, 9, 228–236.
DOI: https://doi.org/10.1002/kpm.155
View in Google Scholar
Subramanian, B., & Bhattacharyya, S. S. (2023). Explicating the factors influencing successful implementation and management of sustainable innovation practices in research-intensive organizations. Journal of Science and Technology Policy Management.
DOI: https://doi.org/10.1108/JSTPM-05-2023-0067
View in Google Scholar
Sun, X., Zuo, L., Zhu, J., & Zhang, K. (2013). The research on business process reengineer internal influencing factors. In International academic workshop on social science (IAW-SC-13) (pp. 218–222). Atlantis Press.
DOI: https://doi.org/10.2991/iaw-sc.2013.47
View in Google Scholar
Tavana, M., Khalili-Damghani, K., & Rahmatian, R. (2015). A hybrid fuzzy MCDM method for measuring the performance of publicly held pharmaceutical companies. Annals of Operations Research, 226, 589–621.
DOI: https://doi.org/10.1007/s10479-014-1738-8
View in Google Scholar
Tetteh, M. G., Jagtap, S., & Salonitis, K. (2022). Pharma 4.0: Revealing drivers of the digital transformation in the pharma sector. In Global conference on sustainable manufacturing (pp. 528–535). Cham: Springer International Publishing.
DOI: https://doi.org/10.1007/978-3-031-28839-5_59
View in Google Scholar
Timmins, P. (2019). Industry update: The latest developments in the field of therapeutic delivery, 1–31 December 2018. Therapeutic Delivery, 10(4), 215–226.
DOI: https://doi.org/10.4155/tde-2019-0003
View in Google Scholar
Turan, C., & Ozturkoglu, Y. (2022). Investigating the performance of the sustainable cold supply chain in the pharmaceutical industry. International Journal of Pharmaceutical and Healthcare Marketing, 16(3), 448–467.
DOI: https://doi.org/10.1108/IJPHM-04-2021-0043
View in Google Scholar
Um, S. I., Kim, C., Ha, T., Kim, J., & Lee, H. (2022). Morphological change and internal growth factors of firms in the Korean pharmaceutical industry in recent decades. Sustainability, 14(22), 15339.
DOI: https://doi.org/10.3390/su142215339
View in Google Scholar
Van den Bogaert, S., Declercq, J., Christiaens, T., Jacobs, G., & Bracke, P. (2018). In the land of pharma: A qualitative analysis of the reputational discourse of the pharmaceutical industry. Public Relations Inquiry, 7(2), 127–147.
DOI: https://doi.org/10.1177/2046147X18774588
View in Google Scholar
Wisniewski, T., & Tundys, B. (2020). Simulated-based approach to analyse sustainable supply chain in a pharmaceutical company. In Meeting 35th International Business-Information-Management-Association Conference (IBIMA), education excellence and innovation management: A 2025 vision to sustain economic development during global challenges, Spain (pp. 85–96). IBIMA.
View in Google Scholar
Workman, P., Draetta, G. F., Schellens, J. H., & Bernards, R. (2017). How much longer will we put up with $100,000 cancer drugs?. Cell, 168(4), 579–583.
DOI: https://doi.org/10.1016/j.cell.2017.01.034
View in Google Scholar
Zhang, S., & Zhu, L. (2022). Drugs quality supervision strategy of different distribution channels in pharmaceutical supply chain. Frontiers in Public Health, 10, 1–16,
DOI: https://doi.org/10.3389/fpubh.2022.954371
View in Google Scholar
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Equilibrium. Quarterly Journal of Economics and Economic Policy
This work is licensed under a Creative Commons Attribution 4.0 International License.
